RecruitingPhase 2NCT05761366

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor


Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrollment

400 participants

Start Date

Oct 13, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, Al18F-PSMA-BCH PET/CT will be performed in patients with prostate specific membrane antigen positive tumor, to evaluate the tumour detection efficacy of Al18F-PSMA-BCH PET/CT.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing the use of a special imaging scan called 18F-PSMA PET/CT — a scan that can detect tumors which express a protein called PSMA — in patients with various types of cancer. The goal is to see whether this imaging technique can better locate and diagnose PSMA-positive tumors across multiple cancer types. **You may be eligible if...** - You are 18 or older, any gender - You have a suspected or confirmed PSMA-expressing cancer (including prostate cancer, bladder cancer, colon cancer, liver cancer, multiple myeloma, and others) - You are willing and able to cooperate with imaging procedures - You have signed the informed consent **You may NOT be eligible if...** - You have serious neurological, gastrointestinal, heart, liver, or kidney conditions - You are pregnant or breastfeeding - You are allergic to the imaging agent or its components Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAl18F-PSMA-BCH PET/CT

Patients will be intravenously injected with Al18F-PSMA-BCH and undergo PET/CT scan.


Locations(1)

National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, Chaoyang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05761366


Related Trials